Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 11/20 | 0.81 |
| ▸ | STAT1 | P42224 | 1/20 | 0.81 |
| ▸ | STAT4 | Q14765 | 1/20 | 0.81 |
| ▸ | XIAP | P98170 | 8/20 | 0.40 |
| ▸ | BIRC3 | Q13489 | 8/20 | 0.40 |
| ▸ | BIRC2 | Q13490 | 8/20 | 0.40 |
| ▸ | STAT5A | P42229 | 1/20 | 0.37 |
| ▸ | STAT5B | P51692 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25228341 | 0.96 | STAT3 (0.88) | STAT3STAT1STAT4XIAPBIRC3 | |
| SCHEMBL30308572 | 0.96 | STAT3 (0.88) | STAT3STAT1STAT4XIAPBIRC3 | |
| SCHEMBL25228342 | 0.96 | STAT3 (0.88) | STAT3STAT1STAT4XIAPBIRC3 | |
| SCHEMBL22468771 | 0.90 | STAT3 (1.00) | STAT3STAT1STAT4XIAPBIRC3 | |
| SCHEMBL22468769 | 0.90 | STAT3 (1.00) | STAT3STAT1STAT4XIAPBIRC3 | |
| SCHEMBL30308498 | 0.90 | STAT3 (1.00) | STAT3STAT1STAT4XIAPBIRC3 | |
| SCHEMBL25210244 | 0.90 | STAT3 (1.00) | STAT3STAT1STAT4XIAPBIRC3 | |
| SCHEMBL25210237 | 0.90 | STAT3 (1.00) | STAT3STAT1STAT4XIAPBIRC3 | |
| SCHEMBL30308610 | 0.90 | STAT3 (1.00) | STAT3STAT1STAT4XIAPBIRC3 | |
| SCHEMBL30308404 | 0.90 | STAT3 (1.00) | STAT3STAT1STAT4XIAPBIRC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020206424-A1 | STAT DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2020-10-08 | — | — | WO | disclosed |